fda glp-1 compounding crackdown september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Demurs on GLP-1 Compounding

Conjugated bilirubin affects cytokine profiles in hepatitis A virus infection by modulating function of signal transducer and activator of transcription factors

Bioengineered 13, 25132524

Doctors typically look at: BMI (Body Mass Index) Existing health conditions (diabetes, hypertension, GERD, etc.) Previous weight loss attempts Lifestyle and readiness for change Many patients fall into this category: BMI 30+ Tried multiple methods Looking for a structured, medically guided solution Sound familiar

doi: 10.1007/s10787-019-00608-2 129 WangYChenJLuoXZhangYSiMWuHet al

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols